Dr Aditi Bhatt
MBBS, MS (General Surgery), MCh. (Surgical Oncology)
Dr Aditi Bhatt is a specialist in the management of peritoneal surface malignancies. She has been performing CRS and HIPEC for appendiceal tumours, pseudomyxoma peritonei, ovarian cancer, colorectal cancer, peritoneal mesothelioma and other peritoneal malignancies for the last 10 years. PIPAC and other palliative treatments for peritoneal malignancies are also available at her centre.
Her key areas of research are surgical therapies for ovarian cancer, outcomes of surgical treatment of peritoneal metastases in the Indian subcontinent and patterns of peritoneal dissemination in various primary and secondary peritoneal malignancies. She is a founding member and the secretary of the Society of Peritoneal Surface Oncology, India (SPSOI) and a member of the executive committee of the Peritoneal Surface Oncology Group International (PSOGI). She has published nearly 75 research papers and edited two books on peritoneal surface malignancies.
Department of surgical oncology,
Zydus Hospital,
Zydus hospital road,
Thaltej,
Ahmedabad 380054,
India
t: 91 9686447863, 91 79 6619 0200, 91 79 6619 0201
e: [email protected], [email protected]
w: www.draditibhatt.com, www.zydushospitals.com
Our medical advisors
Professor Paul Moroz
Prof. Moroz advises Pseudomyxoma Survivor, as a specialist in pseudomyxoma peritonei and HIPEC treatment, based in Australia.
Dr Armando Sardi
Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage, complex cancers of the abdominal region.
Laura Lambert MD
Laura Lambert, MD is a surgical oncologist who specializes in treating peritoneal surface malignancies including pseudomyxoma peritonei.
Mr Omer Aziz
Omer Aziz is a UK-based consultant colorectal surgeon at The Christie and a member of the Pseudomyxoma Survivor medical advisory board.
Prof Wim P Ceelen
Prof Wim Ceelen is a senior GI surgeon at Ghent University Hospital, also an Associate Professor in surgical oncology at Ghent University.
Dr Jason Spendelow
Supporting our commitment to living with pseudomyxoma peritonei and appendix cancer, we welcome Dr Spendelow as a medical advisor.